(HealthDay)—Zerbaxa (ceftolozane and tazobactam) has been approved for a new indication to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years ...
Jun 4, 2019
0
2
(HealthDay)—Risk factors for opioid overdose among hospitalized patients include being age 65 years or older, being in an intensive care unit (ICU), and having renal impairment, according to a study published online May ...
Jun 13, 2018
0
0
(HealthDay)—Recommendations have been developed for the diagnosis and management of multiple myeloma-related renal impairment; the guidelines were published online March 14 in the Journal of Clinical Oncology.
Mar 15, 2016
0
2
Renal cell carcinomas are one of the most common types of cancer. In order to preserve its wide range of functions, every effort is made not to remove the entire kidney, but rather just a portion of it. A surgical method ...
Jul 13, 2015
0
54
Preliminary data from an ongoing study revealed today at The International Liver Congress 2015 suggest that a combination of three direct-acting antivirals (DAAs) plus dasabuvir is well tolerated in patients with severe renal ...
Apr 25, 2015
0
24
Many patients with type 2 diabetes in the United States may be discouraged from taking metformin—a proven, oral diabetes medicine—because the U.S. Food and Drug Administration inappropriately labels the drug unsafe for ...
Jan 5, 2015
0
30
(HealthDay)—For older adults with chronic heart failure, memory impairment is common, with impairment correlating positively with heart failure severity, according to a study published in the April 1 issue of The American ...
Apr 3, 2014
0
0
Final results of a Monash-led three-year clinical trial assessing a novel procedure to treat blood pressure has been published today in the prestigious journal, The Lancet.
Nov 7, 2013
0
0
In the treatment of venous thromboembolism (VTE), the oral anticoagulant edoxaban resulted in equal efficacy and better safety compared to standard warfarin when either drug was used with initial low molecular weight heparin ...
Sep 1, 2013
0
0
A new investigational device - the Helio System (TF-FA) - being developed for use with the Sapien XT Transcatheter Heart Valve was successfully deployed in all four patients in a small, first-in-human feasibility study of ...
May 24, 2013
0
0
